Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Understanding which cash back card offers the most rewards can help you maximize your earnings. Explore your best options now!
27,114 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
If you missed the early AI stock surge, you still have a shot. This guide reveals two aggressive neocloud ideas and h...
European leaders weigh price caps on essentials to curb inflation, a move that has CEOs warning of market distortions...
D-Wave Quantum’s stock sprinted higher this week, but a quick rally doesn’t equal a clear buy. This guide breaks down...
Upstart’s growth engine faces higher costs that squeeze margins, triggering a drop in price even when revenue beats. ...
A high-profile hedge fund billionaire made bold moves, piling into Amazon and Microsoft while slashing a top AI stock...
SpaceX is expanding fast after its IPO, but new debt plans and strategic bets raise questions for investors. This art...
Robinhood unveils a private-market fund designed for everyday investors to back late-stage startups, signaling a shif...
Rhode Island’s small firms drive growth, jobs, and innovation. This article explains how a high-earner surtax would a...
The NEOS Nasdaq-100 High Income ETF (QQQI) shows a 14% headline yield, but most of that payout is return of capital. ...
Vinod Khosla stepped in after Elon Musk pulled back from OpenAI’s pledge, funding a high-stakes bet that transformed ...